logo
Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: melanoma
Load new posts () and activity
Like Reblog Comment
text 2018-05-25 14:59
Melanoma Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Melanoma Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

lobal Melanoma Diagnostics Market: Type of Condition (Superficial Spreading Melanoma, Lentigo Maligna Melanoma, Nodular Melanoma,Acral Lentiginous Melanoma), Type of Test (Dermatoscopy, Optical Coherence Tomography, Multispectral Imaging, Non-invasive Genome Detection, Electrical impedance spectroscopy (EIS), Fiber Diffraction, Tissue Elastography, Thermal Imaging, Positron emission tomography (PET), MRI –Scan, CT-Scan, Sentinel Lymph Node Biopsy), End user (Diagnostic Centers, Hospitals, Ambulatory Surgical Centers) and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

 

Global Melanoma Diagnostics market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2017 to 2023.

 

Market Outline: Melanoma Diagnostics Market

Melanoma is the more serious type of cancer which develops in cells of skin called melanocytes that produce melanin. Melanoma not only affects skin but it also affects eyes and rarely, affects internal organs such as the intestine. The exact cause of melanoma is not clearly known, but the exposure of skin to UV radiation or tanning lumps and beds increases risk of developing melanoma.

 

Market Dynamics: Melanoma Diagnostics Market

Melanoma Diagnostics market is primarily driven by the increase in number of people suffering from melanoma coupled with the advancements and approvals of new technologies for the diagnosis of melanoma. In addition, growing number of developments, current pipeline tests and biomarkers and their expected approvals during the forecast period projected to boost the Melanoma Diagnostics market over the forecast period. Furthermore, increase in government support and R&D activities to fight against cancer coupled with various initiatives by government and non-government organizations expected to bolster the market growth over the forecast period. However, high cost associated with the diagnosis process, regulatory constraints may hinder the growth of Melanoma Diagnostics market globally.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/melanoma-diagnostics-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Market Scope: Melanoma Diagnostics Market

Melanoma Diagnostics market is segmented based on the type of condition, type of test, end user and geographical regions

Based on the type of condition, the market is segmented into the following:

  • Superficial Spreading Melanoma
  • Lentigo Maligna Melanoma
  • Nodular Melanoma
  • Acral Lentiginous Melanoma

Based on the type of test, the market is segmented into the following:

  • Dermatoscopy
  • Optical Coherence Tomography
  • Multispectral Imaging
  • Non-invasive Genome Detection
  • Electrical impedance spectroscopy (EIS)
  • Fiber Diffraction
  • Tissue Elastography
  • Thermal Imaging
  • Positron emission tomography (PET)
  • MRI –Scan
  • CT-Scan
  • Sentinel Lymph Node Biopsy

Based on the end user, the market is segmented into the following:

  • Diagnostic Centers
  • Hospitals
  • Ambulatory Surgical Centers

Based on the geographical regions, the market is segmented into the following:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/melanoma-diagnostics-market/#ulp-c654SbFYO64MsOhu

 

 

Market Summary: Melanoma Diagnostics Market

The upsurge in the global melanoma prevalence rates and pipeline drugs for the treatment of melanoma projected to boost the global Melanoma Diagnostics market at significant rates over the forecast period. According to World Health Organization (WHO), there is continuous increase in global prevalence of melanoma worldwide and estimated to be 132,000 melanoma skin cancers occurs every year. Companies in marketplace are focused on development of the new  biomarker assays and tests for the diagnosis of melanoma. Furthermore, companies also focus on collaborations and acquisitions to develop the new drug treatments and expanding their portfolio in Melanoma Diagnostics market. For instance, in January 2018, Skyline Dx INKS entered into a joint development agreement with mayo clinic to develop diagnostic tests for melanoma

 

Regional Analysis:  Melanoma Diagnostics Market

Geographically, global Melanoma Diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America Melanoma Diagnostics marketexpected to grow at significant rates due to the high prevalence of the disease in the region. According to American Cancer Society, the rates of melanoma are raising from past 30 years and about 91,270 new melanomas will be diagnosed in 2018. In addition, favourable reimbursement policies in the region coupled with the increase in disposable income are expected to boost the market share of the region over the forecast period. Europe Melanoma Diagnostics market projected to grow at notable rates owing to the factors such as growing prevalence of melanoma, presence of key market players in the region and increase in R&D towards the development of new treatments for cancer backed with growing government funding. Asia Pacific Melanoma Diagnostics market projected to have the lucrative growth opportunity due to growing healthcare expenditure by the population and increase in R&D investments by the companies and government in the region.

 

 

Notable Market Developments:  Melanoma Diagnostics Market

  • In January 2014, Michelson diagnostics, UK based medical device company focused on multi beam optical coherence tomography technology and received award of €2.26 million Framework 7 grant to a consortium of seven partners, towards the cost of project targeting malignant with OCT imaging.

 

Competition Assessment: Melanoma Diagnostics Market

Some of the players in the global Melanoma Diagnostics market include:

  • Abbott Laboratories (U.S)
  • Ariad Pharmaceuticals, Inc. (U.S)
  • Pfizer (U.S)
  • Sanofi S.A (France)
  • Novartis (Switzerland)
  • Merck & Co., Inc. (U.S)
  • Becton, Dickinson & Co. (U.S)
  • Eli Lilly and Co (U.S)
  • Siemens Healthcare Inc. (Germany)
  • Hoffman-La Roche Ltd. (Switzerland)
  • GlaxoSmithKline Plc., etc. (UK)
  • AstraZeneca plc  (UK)
  • Bristol-Myers Squibb (U.S)

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/melanoma-diagnostics-market/#ulp-14mlyhjMGhVjZqa3

 

 

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/melanoma-diagnostics-market/

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

Like Reblog Comment
url 2015-03-31 22:24
Cancer Immunization by Dr. Gregory J. Berry

Dr. Gregory J. Berry’s new book, Cancer Immunization, is out now!

For the first time in history, a new path to cancer prevention for those over 40 years of age is disclosed. The common denominator and other bioactive compounds of three different medicinal mushrooms from Japan, China and the Himalayas respected for two millennia have been discovered and Western research into them is presented.

More posts
Your Dashboard view:
Need help?